Career Opportunities

PhysioSense Technologies

We are an early stage startup working on exciting technologies for early diagnosis of critical health conditions affecting millions worldwide. Overwhelming number of Type 2 diabetes patients have Distal Symmetrical Peripheral Neuropathy (DSPN) which, if detected early, can prevent neurological damage. Small-Fiber Neuropathy (SFN), which precedes large-fiber neuropathy, and if detected early, can be halted or modified (by diet, glycemic, blood pressure, and lipid control. Our AI led technology, which has shown great potential in early stage research, will leverage Electrodermal activity (EDA) to detect subclinical or advanced SFN, discriminate between SFN severity levels, and track the progression of SFN using wearable devices. Frequently, Atrial Fibrillation (A-fib) is asymptomatic which causes major long-term health consequences and long-term, continuous monitoring can significantly reduce healthcare costs. We are developing minimally obtrusive lead-less wearable A-fib detection devices the user can live in, long term leveraging AI and advanced sensing technology. Our technology – which has shown promising early results – can disrupt the traditional delivery of A-fib healthcare.
Newtown, CT, USA
Inaccurate data? Flag it here.
Open jobs at PhysioSense Technologies
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.
We only use strictly necessary, first-party cookies on this job board. These are cookies that are necessary to deliver this service to you, or are necessary for Connecticut Innovations to understand how it is being used. Read our Cookie Policy.